Thyroidectomy without Radioiodine in Patients with Low-Risk Thyroid Cancer with Dr. Genere скачать в хорошем качестве

Thyroidectomy without Radioiodine in Patients with Low-Risk Thyroid Cancer with Dr. Genere

We are proud to have Natalia Genere, MD present, "Thyroidectomy without Radioiodine in Patients with Low-Risk Thyroid Cancer." Discussion with David Cooper, MD. 0:00 Webinar 2:50 Presentation Begins 4:08 Why It's Important to Study Low-Risk Thyroid Cancer Dr. Genere provides some background on epidemiology and guidelines for what constitutes low-risk thyroid cancer. 9:16 Summary of Existing Literature Dr. Genere summarizes the existing literature regarding the use of radioactive iodine (RAI) to treat low-risk differentiated thyroid carcinoma (DTC), and how her research fills in a gap in that literature. 15:32 Designing a Randomized Controlled Trial Dr. Genere walks through the objective and methods of a randomized controlled trial comparing low-risk DTC patients who did and didn’t receive RAI ablation in addition to thyroidectomy. 23:29 What Does RAI Affect? Dr. Genere summarizes the results of the study, focusing on discussing event frequency, response to therapy, quality of life, and molecular markers. 28:01 Limitations & Clinical Implications Dr. Genere discusses limitations and summarizes important findings from the trial. 30:11 Discussion with Q&A ** Check out our other programs! ** The THANC Guide https://thancguide.org/ TIRO: Thyroid Int'l Recommendations Online https://tiro.expert/ ** Follow us on Twitter! ** @thancfoundation - https://shorturl.at/puwS0 THANC on FB - https://shorturl.at/svNY4